TG Therapeutics's total assets for Q3 2024 were $586.01M, an increase of 46.06% from the previous quarter. TGTX total liabilities were $393.86M for the fiscal quarter, a 76.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.